MYLAN-OLANZAPINE ODT
MYLAN-OLANZAPINE ODT
Discontinued
DIN Number
02382733
Drug Class
Human
Market Date
Mar 30, 2012
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02382733
AIG Number0128783006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AH03 OLANZAPINE
Product Specifications
Dosage FormTablet (Orally Disintegrating)
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
OLANZAPINEActive
Strength: 20 MG
Monograph: OLANZAPINE